Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
EVAHEART 2 Left Ventricular Assist System: A Hemocompatible Centrifugal Pump with Physiological Pulsatility | SpringerLink
Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: A Japanese multicenter study using J-MACS - The Journal of Heart and Lung Transplantation
Hershey Medical Center Second in the Nation to Implant EvaHeart2 LVAD | DAIC
Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device‐specific LVAD management - Bartoli - 2020 - Journal of Cardiac Surgery - Wiley Online Library
New era for therapeutic strategy for heart failure: Destination therapy by left ventricular assist device - ScienceDirect
The Next Wave of Mechanical Circulatory Support Devices
EVAHEART 2 Left Ventricular Assist System: A Hemocompatible Centrifugal Pump with Physiological Pulsatility | SpringerLink
Evaheart - Crunchbase Company Profile & Funding
Clinical implications of hemodynamic assessment during left ventricular assist device therapy - Journal of Cardiology
Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
Study on Visualization of Ventricular Assist Device Development Process using System Dynamics
EVAHEART - YouTube
The Next Wave of Mechanical Circulatory Support Devices - Cardiac Interventions Today
Hayden man is first outside Japan to receive new heart implant - News | UAB
Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: A Japanese multicenter study using J-MACS - The Journal of Heart and Lung Transplantation
Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
Living with the EVAHEART®2 — Rotary pump yet pulsatile
Centrifugal LVAS — Rotary pump yet pulsatile
Evaheart Technology - Applied Medical Science — Rotary pump yet pulsatile
Anh-Alisse Selissen - Clinical Support Specialist - Evaheart, Inc. | LinkedIn
